Angela Jain

1.7k total citations
14 papers, 68 citations indexed

About

Angela Jain is a scholar working on Oncology, Reproductive Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Angela Jain has authored 14 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Reproductive Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Angela Jain's work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Mechanisms and Therapy (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Angela Jain is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Cancer Mechanisms and Therapy (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Angela Jain collaborates with scholars based in United States and Canada. Angela Jain's co-authors include Michael V. Seiden, Paula D. Ryan, Gina Mantia-Smaldone, Elizabeth A. Handorf, Safoora Deihimi, James S. Duncan, Robert L. Coleman, Cara Mathews, Alison Kurimchak and Denise C. Connolly and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Science Signaling.

In The Last Decade

Angela Jain

14 papers receiving 68 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Jain United States 4 35 23 20 15 12 14 68
Lindsey Beffa United States 5 34 1.0× 10 0.4× 30 1.5× 26 1.7× 6 0.5× 16 92
Ana Santaballa Bertrán Spain 5 40 1.1× 30 1.3× 18 0.9× 9 0.6× 15 1.3× 11 81
E.M. Guerra Spain 4 36 1.0× 43 1.9× 26 1.3× 8 0.5× 8 0.7× 8 77
Sarah Farooq United States 6 32 0.9× 64 2.8× 19 0.9× 11 0.7× 6 0.5× 10 84
Jin Suminokura Japan 5 16 0.5× 22 1.0× 13 0.7× 10 0.7× 6 0.5× 9 46
Isabell Ge Germany 6 14 0.4× 47 2.0× 28 1.4× 16 1.1× 6 0.5× 11 127
Dennis Mauricio United States 3 13 0.4× 36 1.6× 23 1.1× 33 2.2× 9 0.8× 6 92
E. Salinas United States 6 51 1.5× 23 1.0× 43 2.1× 35 2.3× 3 0.3× 22 105
Shanshan Yang China 4 21 0.6× 14 0.6× 21 1.1× 4 0.3× 15 1.3× 4 58
Simona Ruisi Italy 2 36 1.0× 36 1.6× 19 0.9× 4 0.3× 8 0.7× 2 71

Countries citing papers authored by Angela Jain

Since Specialization
Citations

This map shows the geographic impact of Angela Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Jain more than expected).

Fields of papers citing papers by Angela Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Jain. The network helps show where Angela Jain may publish in the future.

Co-authorship network of co-authors of Angela Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Jain. A scholar is included among the top collaborators of Angela Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Jain. Angela Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deng, Mengying, et al.. (2022). Trends in frontline PARP inhibitor maintenance in advanced epithelial ovarian cancer across the United States.. Journal of Clinical Oncology. 40(16_suppl). 5581–5581. 1 indexed citations
2.
Kurimchak, Alison, Valerie L. Sodi, Nishi Srivastava, et al.. (2020). Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma. Science Signaling. 13(619). 19 indexed citations
3.
Handorf, Elizabeth A., et al.. (2017). National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer. International Journal of Gynecological Cancer. 27(7). 1408–1415. 4 indexed citations
4.
Dhani, Neesha C., Qian Tan, Angela Jain, et al.. (2017). Exploratory phase II evaluation of cabozantinib in recurrent/metastatic uterine carcinosarcoma (CS): A study of the Princess Margaret, Chicago, and California phase II consortia.. Journal of Clinical Oncology. 35(15_suppl). 5587–5587. 1 indexed citations
5.
Dhani, Neesha C., Hal W. Hirte, Julia V. Burnier, et al.. (2017). Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.. Journal of Clinical Oncology. 35(15_suppl). 5524–5524. 3 indexed citations
6.
Jain, Angela, et al.. (2017). Inpatient 100% mortality review at a NCI Comprehensive Cancer Center Hospital.. Journal of Clinical Oncology. 35(8_suppl). 88–88. 2 indexed citations
7.
Zibelman, Matthew R., Alexander W. Macfarlane, R. Katherine Alpaugh, et al.. (2017). Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors.. Journal of Clinical Oncology. 35(7_suppl). 97–97. 1 indexed citations
8.
Dhani, Neesha C., Hal W. Hirte, Marcus O. Butler, et al.. (2016). Phase II study of cabozantinib in recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago and California Phase II Consortia.. Journal of Clinical Oncology. 34(15_suppl). 5586–5586. 1 indexed citations
9.
10.
Jain, Angela, Elizabeth A. Handorf, & Gina Mantia-Smaldone. (2015). The use of adjuvant treatment in stage I endometrioid endometrial cancer in the National Cancer Database (NCDB).. Journal of Clinical Oncology. 33(15_suppl). 5599–5599. 1 indexed citations
11.
Jain, Angela & Michael V. Seiden. (2013). Rare Epithelial Tumors Arising in or near the Ovary: A Review of the Risk Factors, Presentation, and Future Treatment Direction for Ovarian Clear Cell and Mucinous Carcinoma. American Society of Clinical Oncology Educational Book. e200–e204. 3 indexed citations
12.
Jain, Angela & Michael V. Seiden. (2013). Rare Epithelial Tumors Arising in or near the Ovary: A Review of the Risk Factors, Presentation, and Future Treatment Direction for Ovarian Clear Cell and Mucinous Carcinoma. American Society of Clinical Oncology Educational Book. 33. e200–e204. 3 indexed citations
13.
Jain, Angela, Paula D. Ryan, & Michael V. Seiden. (2012). Metastatic Mucinous Ovarian Cancer and Treatment Decisions Based on Histology and Molecular Markers Rather Than the Primary Location. Journal of the National Comprehensive Cancer Network. 10(9). 1076–1080. 23 indexed citations
14.
Jain, Angela, et al.. (1985). Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.. PubMed. 80(11). 835–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsey Beffa Breakdown of academic impact, for papers by Ana Santaballa Bertrán Breakdown of academic impact, for papers by E.M. Guerra Breakdown of academic impact, for papers by Sarah Farooq Breakdown of academic impact, for papers by Jin Suminokura Breakdown of academic impact, for papers by Isabell Ge Breakdown of academic impact, for papers by Dennis Mauricio Breakdown of academic impact, for papers by E. Salinas Breakdown of academic impact, for papers by Shanshan Yang Breakdown of academic impact, for papers by Simona Ruisi
Rankless by CCL
2026